Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-022183
Filing Date
2025-02-18
Accepted
2025-02-18 16:00:41
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K idya-20241231.htm   iXBRL 10-K 4251981
2 EX-4.3 idya-ex4_3.htm EX-4.3 49472
3 EX-10.12 idya-ex10_12.htm EX-10.12 188731
4 EX-10.27 idya-ex10_27.htm EX-10.27 648431
5 EX-10.19(B) idya-ex10_19b.htm EX-10.19(B) 89074
6 EX-10.20(F) idya-ex10_20f.htm EX-10.20(F) 51281
7 EX-10.25(B) idya-ex10_25b.htm EX-10.25(B) 141439
8 EX-19.1 idya-ex19_1.htm EX-19.1 183348
9 EX-23.1 idya-ex23_1.htm EX-23.1 3162
10 EX-31.1 idya-ex31_1.htm EX-31.1 18680
11 EX-31.2 idya-ex31_2.htm EX-31.2 18426
12 EX-32.1 idya-ex32_1.htm EX-32.1 16036
13 GRAPHIC img34507759_0.jpg GRAPHIC 270355
14 GRAPHIC img34507759_1.jpg GRAPHIC 431624
15 GRAPHIC img42081897_0.jpg GRAPHIC 702334
  Complete submission text file 0000950170-25-022183.txt   17140249

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20241231.xsd EX-101.SCH 1444013
92 EXTRACTED XBRL INSTANCE DOCUMENT idya-20241231_htm.xml XML 2156656
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38915 | Film No.: 25634732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)